Long-Term Survival of FOLFIRINOX +toripalimab in a Patient with Metastatic Pancreatic Ductal Adenocarcinoma: A Case Report

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) remains one of the most fatal diseases, with its morbidity and mortality showing an upward trend. The application of monotonous immune checkpoint inhibitor (ICI) in PDAC comes to a disappointing endpoint, despite of its great advancements achieved...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Ting, Gao, Chen, Luo, Yiyang, Ye, Zixiang, Wang, Binbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423048/
https://www.ncbi.nlm.nih.gov/pubmed/36046467
http://dx.doi.org/10.2147/OTT.S369772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423048/
https://www.ncbi.nlm.nih.gov/pubmed/36046467
http://dx.doi.org/10.2147/OTT.S369772

Ejemplares similares